The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland

Mandatory generic substitution (GS) was introduced in Finland on 1 April 2003. The aim of this study was to explore and compare the impacts of GS on the activities of pharmaceutical companies representing mainly original or generic pharmaceutical products in Finland. The self-reported impact of GS f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC clinical pharmacology 2010-10, Vol.10 (1), p.15-15, Article 15
Hauptverfasser:	Timonen, Johanna, Bengtström, Marina, Karttunen, Pekka, Ahonen, Riitta
Format:	Artikel
Sprache:	eng
Schlagworte:	Commerce - statistics & numerical data Competition Cross-Sectional Studies Drug Costs Drug Industry - statistics & numerical data Drug Prescriptions - statistics & numerical data Drug stores Drug Substitution - psychology Drugs, Generic - economics Drugs, Generic - therapeutic use Finland Generic drugs Generic products Health aspects Health sciences Humans Marketing - statistics & numerical data Medical care, Cost of Medicine Pharmaceutical industry Pharmacies Prospective Studies Reference books Sales Society Studies Surveys Surveys and Questionnaires Workload
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!